Clinical trial
Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A…
NCT00213096 · Population Council, Other · Completed
Key facts
| NCT number | NCT00213096 |
|---|---|
| Title | Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive |
| Official title | A Randomized, Open-Label Study Comparing the Effect of a Contraceptive Vaginal Ring Delivering Daily Doses of 150 Micrograms Nestorone and 15 Micrograms Ethinyl Estradiol to an Oral Contraceptive Containing 150 Micrograms of Levonorgestrel and 30 Micrograms of Ethinyl Estradiol Per Tablet on Hepatic… |
| Lead sponsor | Population Council, Other |
| Collaborators | United States Agency for International Development (USAID) U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | Nestorone/ethinyl estradiol contraceptive vaginal ring, levonorgestrel/ethinyl estradiol oral contraceptive |
| Enrollment | 50 |
| Start date | Mar 1, 2003 |
| Completion | Feb 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 14, 2017 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: